These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38623231)

  • 1. Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study.
    Zhou J; Yu X; Wu Q; Wu Y; Fu C; Wang Y; Hai M; Tan H; Wang M
    Heliyon; 2024 Apr; 10(7):e28722. PubMed ID: 38623231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral and Peritumoral Analysis of Mammography, Tomosynthesis, and Multiparametric MRI for Predicting Ki-67 Level in Breast Cancer: a Radiomics-Based Study.
    Jiang T; Song J; Wang X; Niu S; Zhao N; Dong Y; Wang X; Luo Y; Jiang X
    Mol Imaging Biol; 2022 Aug; 24(4):550-559. PubMed ID: 34904187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
    Jiang W; Meng R; Cheng Y; Wang H; Han T; Qu N; Yu T; Hou Y; Xu S
    J Magn Reson Imaging; 2024 Feb; 59(2):613-625. PubMed ID: 37199241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral and Peritumoral Multiparametric MRI-Based Radiomics Signature for Preoperative Prediction of Ki-67 Proliferation Status in Glioblastoma: A Two-Center Study.
    Zhu X; He Y; Wang M; Shu Y; Lai X; Gan C; Liu L
    Acad Radiol; 2024 Apr; 31(4):1560-1571. PubMed ID: 37865602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MR Imaging Radiomics Signatures for Assessing the Recurrence Risk of ER+/HER2- Breast Cancer Quantified With 21-Gene Recurrence Score.
    Chen Y; Tang W; Liu W; Li R; Wang Q; Shen X; Gong J; Gu Y; Peng W
    J Magn Reson Imaging; 2023 Aug; 58(2):444-453. PubMed ID: 36440706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Signatures Based on Multiparametric MRI for the Preoperative Prediction of the HER2 Status of Patients with Breast Cancer.
    Zhou J; Tan H; Li W; Liu Z; Wu Y; Bai Y; Fu F; Jia X; Feng A; Liu H; Wang M
    Acad Radiol; 2021 Oct; 28(10):1352-1360. PubMed ID: 32709582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
    Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
    J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral and Peritumoral Radiomics Based on Functional Parametric Maps from Breast DCE-MRI for Prediction of HER-2 and Ki-67 Status.
    Li C; Song L; Yin J
    J Magn Reson Imaging; 2021 Sep; 54(3):703-714. PubMed ID: 33955619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra- and peri-tumoral radiomics for predicting the sentinel lymph node metastasis in breast cancer based on preoperative mammography and MRI.
    Cheng Y; Xu S; Wang H; Wang X; Niu S; Luo Y; Zhao N
    Front Oncol; 2022; 12():1047572. PubMed ID: 36578933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
    Zheng S; Yang Z; Du G; Zhang Y; Jiang C; Xu T; Li B; Wang D; Qiu Y; Lin D; Zhang X; Shen J
    Eur Radiol; 2024 Sep; 34(9):6132-6144. PubMed ID: 38363315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra- and Peritumoral Radiomics Model Based on Early DCE-MRI for Preoperative Prediction of Molecular Subtypes in Invasive Ductal Breast Carcinoma: A Multitask Machine Learning Study.
    Zhang S; Wang X; Yang Z; Zhu Y; Zhao N; Li Y; He J; Sun H; Xie Z
    Front Oncol; 2022; 12():905551. PubMed ID: 35814460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
    Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
    Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiregional Radiomic Signatures Based on Functional Parametric Maps from DCE-MRI for Preoperative Identification of Estrogen Receptor and Progesterone Receptor Status in Breast Cancer.
    Zhong S; Wang F; Wang Z; Zhou M; Li C; Yin J
    Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra- and peritumoral radiomics on assessment of breast cancer molecular subtypes based on mammography and MRI.
    Niu S; Jiang W; Zhao N; Jiang T; Dong Y; Luo Y; Yu T; Jiang X
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):97-106. PubMed ID: 34623517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Radiomics to Differentiate Brain Metastases From Lung Cancer Versus Breast Cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
    Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
    J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical study on the prediction of ALN metastasis based on intratumoral and peritumoral DCE-MRI radiomics and clinico-radiological characteristics in breast cancer.
    Wang Y; Shang Y; Guo Y; Hai M; Gao Y; Wu Q; Li S; Liao J; Sun X; Wu Y; Wang M; Tan H
    Front Oncol; 2024; 14():1357145. PubMed ID: 38567148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of MRI Radiomics Models to Differentiate HER2-Zero, -Low, and -Positive Breast Cancer.
    Peng Y; Zhang X; Qiu Y; Li B; Yang Z; Huang J; Lin J; Zheng C; Hu L; Shen J
    AJR Am J Roentgenol; 2024 Apr; 222(4):e2330603. PubMed ID: 38265001
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiparametric MRI Radiomics With Machine Learning for Differentiating HER2-Zero, -Low, and -Positive Breast Cancer: Model Development, Testing, and Interpretability Analysis.
    Chen Y; Chen S; Tang W; Kong Q; Zhong Z; Yu X; Sui Y; Hu W; Jiang X; Guo Y
    AJR Am J Roentgenol; 2024 Oct; ():. PubMed ID: 39413232
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.